What's Happening?
Researchers have developed a new imaging method that allows for the tracking of cancer progression from the whole body down to individual cells. This approach combines multiple imaging techniques, such as PET scans, bioluminescence, and fluorescence,
to detect tumors across the body and examine them in detail. The method, demonstrated in liver and lung cancer models, provides a clearer understanding of tumor behavior at both macro and micro levels. This advancement could lead to more precise cancer treatments by allowing researchers to study tumors individually rather than treating them as biologically identical. The study, led by Professor David Lewis from the Cancer Research UK Scotland Institute and University of Glasgow, is published in Nature Biotechnology.
Why It's Important?
This new imaging method represents a significant advancement in cancer research, offering a more comprehensive understanding of tumor behavior. By linking large-scale imaging with cellular-level analysis, researchers can better understand why tumors behave differently and why some respond to therapy while others do not. This could lead to the development of more effective and personalized cancer treatments. The ability to track cancer progression at such a detailed level also opens the door to more precise preclinical testing, potentially accelerating the development of new therapies. This approach could be applied across multiple fields, including oncology, immunology, neuroscience, and regenerative medicine.
What's Next?
While the technology is currently available only for research use in mice, its potential application in human patients could revolutionize cancer treatment. Researchers aim to further develop this method to better reflect the underlying biology of cancer in humans. The next steps involve refining the technology for clinical use and exploring its application in other types of cancer. As the method becomes more widely adopted, it could lead to significant improvements in cancer diagnosis and treatment, ultimately improving patient outcomes.
